Abstract | OBJECTIVE: METHODS: Clinical data of 28 children with severe aplastic anemia who received ATG/ALG treatment from December, 1994 through to September, 2005 were analyzed retrospectively. RESULTS: Of the 28 patients, 2 were nearly cured (7.1%), 4 were relieved (14.3%) and 12 were improved (42.9%) based on a hemoglobin/white blood cell/platelet count. These results represented an overall effective rate of 64.3%. Clinical evidence of serum sickness developed in 19 patients, manifesting as fever (n = 9), cutaneous eruptions (n = 12), arthralgias (n = 7), myalgia (n = 7) and arthrocele (n = 3). Serum sickness occurred 5-17 days after ATG/ALG administration and lasted for 1-15 days (mean 4.4 days). Three children with mild serum sickness symptoms recovered without any treatment. The symptoms of the other 16 patients disappeared after 3-5 days of methylprednisolone treatment (10 mg/kg daily). However, 3 patients had relapses at 2-4 days after termination of methylprednisolone therapy. Another course of methylprednisolone therapy was administered to the 3 patients until the symptoms disappeared. The patients with no serum sickness or with mild serum sickness had a better response to ATG/ALG therapy than those who had severe serum sickness (100% vs 60%; P < 0.05). CONCLUSIONS:
|
Authors | Fang Yu, Suo-Qin Tang, Jian-Wen Wang |
Journal | Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics
(Zhongguo Dang Dai Er Ke Za Zhi)
Vol. 8
Issue 6
Pg. 479-81
(Dec 2006)
ISSN: 1008-8830 [Print] China |
PMID | 17178040
(Publication Type: English Abstract, Journal Article)
|
Chemical References |
|
Topics |
- Anemia, Aplastic
(drug therapy)
- Antilymphocyte Serum
(adverse effects, therapeutic use)
- Child
- Child, Preschool
- Female
- Humans
- Infant
- Male
- Serum Sickness
(etiology)
- T-Lymphocytes
(immunology)
|